The expression of CXCL12 and IL7R in normal patients is higher than that of LIHC patients (Figure 5B), indicating that CXCL12 and IL7R are associated with tumorigenesis, but whether high expression can inhibit tumorigenesis and development, while low expression can promote tumor progression, is to be further discussed. Here, CXCL12 is linked to neoplasm.